gopubmed logo
find other proteinsAll proteins
GoPubMed Proteins lists recent and important papers and reviews for proteins. Page last changed on 19 Aug 2016.

Ubiquitin associated protein 2-like

Top mentioned proteins: Ubiquitin, CAN, CD45, Tec, Gp
Papers on NICE-4
Arginine methylation of ubiquitin-associated protein 2-like is required for the accurate distribution of chromosomes.
Senga et al., Nagoya, Japan. In Faseb J, Jan 2016
In this article, we show that ubiquitin-associated protein 2-like (UBAP2L) is necessary for correct kinetochore-microtubule attachment.
Downregulation of ubiquitin-associated protein 2-like with a short hairpin RNA inhibits human glioma cell growth in vitro.
Bian et al., Hefei, China. In Int J Mol Med, Oct 2015
Ubiquitin-associated protein 2-like (UBAP2L), which contains a ubiquitin-associated (UBA) domain near its N-terminus, has been indicated in the pathogenesis of several human cancers, including multiple myeloma, hepatocellular carcinoma and malignant ovarian tumors.
UBAP2L is a novel BMI1-interacting protein essential for hematopoietic stem cell activity.
Sauvageau et al., Montréal, Canada. In Blood, 2014
Toward this goal, we isolated BMI1-containing protein complexes and identified UBAP2L as a novel BMI1-interacting protein.
Knockdown of ubiquitin associated protein 2-like inhibits the growth and migration of prostate cancer cells.
Huang et al., Shanghai, China. In Oncol Rep, 2014
Ubiquitin associated protein 2-like (UBAP2L) is believed to be involved in the ubiquitin‑proteasome pathway; however, the role of UBAP2L in human prostate cancer is still unknown.
Proteomic characterization of aggregating proteins after the inhibition of the ubiquitin proteasome system.
Mayor et al., Vancouver, Canada. In J Proteome Res, 2011
We also identified the ubiquitin-associated protein 2 like (UBAP2L).
Identification of human sperm proteins that interact with human zona pellucida3 (ZP3) using yeast two-hybrid system.
Dhandapani et al., Morgantown, United States. In J Reprod Immunol, 2010
Of these, the strongest ZP3-interacting protein, that shows 97% homology with ubiquitin associated protein-2 like (UBAP2L), was tested in the hemizona assay.
Identification of c-Src tyrosine kinase substrates using mass spectrometry and peptide microarrays.
Pandey et al., Baltimore, United States. In J Proteome Res, 2008
We have experimentally validated 4 of the novel proteins (NICE-4, RNA binding motif 10, FUSE-binding protein 1 and TRK-fused gene) as direct substrates of c-Src using in vitro kinase assays and cotransfection experiments.
Phosphoproteome analysis of HeLa cells using stable isotope labeling with amino acids in cell culture (SILAC).
Pandey et al., Baltimore, United States. In J Proteome Res, 2005
We validated the phosphorylation status of a subset of novel proteins including cytoskeleton associated protein 1, breast cancer anti-estrogen resistance 3, chromosome 3 open reading frame 6, WW binding protein 2, Nice-4 and RNA binding motif protein 4. Our strategy can be used to identify potential kinase substrates without prior knowledge of the signaling pathways and can also be applied to profiling to specific kinases in cells.
Pharmacokinetics of enoxaparin in patients undergoing percutaneous coronary intervention with and without glycoprotein IIb/IIIa therapy.
Fareed et al., United States. In Am J Ther, 2003
Patients enrolled in the NICE-4 trial received enoxaparin as a 0.75-mg/kg intravenous bolus followed by abciximab as a 0.25-mg/kg bolus and a 0.125-mcg/kg/min 12-hour infusion.
Safety and efficacy of low-dose intravenous enoxaparin and GP IIb/IIIa inhibitor therapy during PCI.
Warner et al., Harrisonburg, United States. In J Invasive Cardiol, 2003
NICE-4, a recent PCI observational study, evaluated a reduced dose of intravenous (IV) enoxaparin (0.75 mg/kg) with abciximab.
Identification of human epidermal differentiation complex (EDC)-encoded genes by subtractive hybridization of entire YACs to a gridded keratinocyte cDNA library.
Mischke et al., Berlin, Germany. In Genome Res, 2001
The genes encode cytoskeletal tropomyosin TM30nm (TPM3), HS1-binding protein Hax-1 (HAX1), RNA-specific adenosine deaminase (ADAR1), the 34/67-kD laminin receptor (LAMRL6), and the 26S proteasome subunit p31 (PSMD8L), as well as five hitherto uncharacterized proteins (NICE-1, NICE-2, NICE-3, NICE-4, and NICE-5).
Glycoprotein IIb/IIIa inhibitors and low-molecular-weight heparins: a combined role in coronary interventions?
Fry, Indianapolis, United States. In Clin Cardiol, 2001
Similar results were demonstrated in the National Investigators Collaborating on Enoxaparin (NICE-4) study using a combination of abciximab and enoxaparin in patients undergoing PCI.
Combination enoxaparin and abciximab therapy during percutaneous coronary intervention: "NICE guys finish first".
Cohen et al., Cincinnati, United States. In J Invasive Cardiol, 2000
The preliminary experience with combining abciximab and intravenous enoxaparin during percutaneous coronary intervention in the NICE-4 Trial demonstrates a low incidence of minor/major bleeding (TIMI definition) and transfusion and infrequent major cardiac events to 30 days follow-up.
share on facebooktweetadd +1mail to friends